Skip to content
10-K

Annual Report

CERO THERAPEUTICS HOLDINGS, INC. CERO CEROW

0001213900-26-044040

← back to feed
Filed
Apr 15, 2026 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Dividends Paid FY 2025 · Dec 31, 2025 $127.14K
Operating Cash Flow FY 2025 · Dec 31, 2025 −$16.1M
Stockholders Equity FY 2025 · Dec 31, 2025 −$5.45M
Stockholders Equity FY 2025 · Dec 31, 2024 −$1.89M
Stockholders Equity FY 2025 · Feb 14, 2024 −$2.35M
Current Liabilities FY 2025 · Dec 31, 2025 $9.09M
Current Liabilities FY 2025 · Dec 31, 2024 $7.4M
Total Liabilities FY 2025 · Dec 31, 2025 $9.09M
Total Liabilities FY 2025 · Dec 31, 2024 $8.1M
Current Assets FY 2025 · Dec 31, 2025 $2.73M
Current Assets FY 2025 · Dec 31, 2024 $3.71M
Total Assets FY 2025 · Dec 31, 2025 $3.64M
Total Assets FY 2025 · Dec 31, 2024 $6.21M
Net Income FY 2025 · Dec 31, 2025 −$19.92M